Literature DB >> 32096176

MiRNA-584 suppresses the progression of ovarian cancer by negatively regulating LPIN1.

L Yang1, H-L Ma.   

Abstract

OBJECTIVE: The aim of the study was to detect the expression level of microRNA-584 (miRNA-584) in ovarian cancer (OCa) and to elucidate its regulatory effect on OCa progression by regulating LPIN1. PATIENTS AND METHODS: Expression levels of miRNA-584 and LPIN1 in 31 matched OCa tissues and paracancerous tissues were detected. The relationship of miRNA-584 level with clinical indicators and prognosis of OCa patients was analyzed. Influences of miRNA-584/LPIN1 regulatory loop on malignant phenotypes of OVCAR3 and PEO1 cells were assessed. In addition, the interaction between miRNA-584 and LPIN1 was confirmed by Dual-Luciferase reporter gene assay and rescue experiments.
RESULTS: MiRNA-584 was lowly expressed in OCa tissues, while LPIN1 was highly expressed. OCa patients expressing a low level of miRNA-584 suffered from higher rates of lymphatic metastasis and distant metastasis, as well as worse survival. The overexpression of miRNA-584 in OVCAR3 cells attenuated proliferative and migratory abilities, while the knockdown of miRNA-584 in PEO1 cells yielded the opposite results. LPIN1 was verified to be the target binding to miRNA-584 and its level was negatively regulated by miRNA-584. The overexpression of LPIN1 accelerated OCa cells to proliferate and migrate. Importantly, LPIN1 was responsible for OCa progression regulated by miRNA-584.
CONCLUSIONS: MiRNA-584 is downregulated in OCa tissues and cell lines. MiRNA-584 level is correlated with lymphatic metastasis, distant metastasis, and poor prognosis in OCa patients. By negatively regulating LPIN1, miRNA-584 suppresses the malignant progression of OCa.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 32096176     DOI: 10.26355/eurrev_202002_20156

Source DB:  PubMed          Journal:  Eur Rev Med Pharmacol Sci        ISSN: 1128-3602            Impact factor:   3.507


  6 in total

Review 1.  Lipin-1, a Versatile Regulator of Lipid Homeostasis, Is a Potential Target for Fighting Cancer.

Authors:  Laura Brohée; Julie Crémer; Alain Colige; Christophe Deroanne
Journal:  Int J Mol Sci       Date:  2021-04-23       Impact factor: 5.923

Review 2.  The diversity and breadth of cancer cell fatty acid metabolism.

Authors:  Shilpa R Nagarajan; Lisa M Butler; Andrew J Hoy
Journal:  Cancer Metab       Date:  2021-01-07

3.  Long non-coding RNA ARAP1-AS1 contributes to cell proliferation and migration in clear cell renal cell carcinoma via the miR-361-3p/placental growth factor axis.

Authors:  Liping Zhong; Xiuwen Zhong
Journal:  Bioengineered       Date:  2021-12       Impact factor: 3.269

4.  A comprehensive analysis of age-related metabolomics and transcriptomics reveals metabolic alterations in rat bone marrow mesenchymal stem cells.

Authors:  Xiao Yu; Hui Sun; Xingyu Gao; Chang Zhang; Yanan Sun; Huan Wang; Haiying Zhang; Yingai Shi; Xu He
Journal:  Aging (Albany NY)       Date:  2022-01-30       Impact factor: 5.682

5.  Circulating ciRS-7 as a potential non-invasive biomarker for epithelial ovarian cancer: An investigative study.

Authors:  Aferin Beilerli; Sema Begliarzade; Albert Sufianov; Tatiana Ilyasova; Yanchao Liang; Ozal Beylerli
Journal:  Noncoding RNA Res       Date:  2022-07-31

Review 6.  The Role of microRNAs in Epithelial Ovarian Cancer Metastasis.

Authors:  Vu Hong Loan Nguyen; Chenyang Yue; Kevin Y Du; Mohamed Salem; Jacob O'Brien; Chun Peng
Journal:  Int J Mol Sci       Date:  2020-09-25       Impact factor: 5.923

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.